SECsense Logo

Pfizer Inc. 8-K Report: Key Updates and Debt Insights - December 2024

$PFE
Form 8-K
Filed on: 2024-12-17
Source
Pfizer Inc. 8-K Report: Key Updates and Debt Insights - December 2024

Based on the provided section of the financial report, the following key information and insights can be extracted:

  1. Entity Information:
  • Company Name: Pfizer Inc.
  • CIK: 0000078003 (Central Index Key for SEC filings).
  • Location: 66 Hudson Boulevard East, New York, NY, 10001-2192.
  • Phone Number: 212-733-2323.
  1. Filing Details:
  • Filing Type: 8-K (reporting significant events).
  • Filing Date: December 17, 2024.
  1. Stock Information:
  • Common Stock: Par value of $0.05.
  • Ticker Symbol: PFE (traded on NYSE).
  1. Debt Instrument:
  • Notes: 1.000% Notes due 2027.
  • Ticker Symbol for Notes: PFE27 (traded on NYSE).
  1. Reporting Period:
  • The reporting period covered in this filing is a single day, December 17, 2024.
  1. Segment Information:
  • There are references to segments for "Common Stock" and "Notes Due 2027", indicating that the report may include specific details related to these financial instruments.

Insights:

  • Corporate Activity: The filing of an 8-K indicates that Pfizer Inc. is communicating a significant event or update to investors, which could relate to corporate actions, financial condition, or other material changes.
  • Debt Obligations: The existence of 1.000% Notes due 2027 suggests Pfizer is managing debt with a relatively low interest rate, which may reflect favorable borrowing conditions or the company's strong creditworthiness.
  • Market Presence: Being listed on the NYSE with a recognizable ticker symbol (PFE) reflects Pfizer's established position in the market.

Overall, this report section provides vital information about Pfizer’s stock and debt instruments, as well as key identifiers that facilitate tracking its financial activities in the market.